Department of Neuroscience and Graduate Program in Neuroscience, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts 02111, Graduate Program in Biochemical and Molecular Nutrition, Gerald J. and Dorothy R. Friedman School of Nutrition and Science Policy, Tufts University, Boston, Massachusetts 02111, and Department of Neurology and Gene Therapy Center, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
J Neurosci. 2014 Jan 8;34(2):554-65. doi: 10.1523/JNEUROSCI.1572-13.2014.
Brain-derived neurotrophic factor (BDNF) and its receptor, TrkB, are critical components of the neural circuitry controlling appetite and body weight. Diminished BDNF signaling in mice results in severe hyperphagia and obesity. In humans, BDNF haploinsufficiency and the functional Bdnf Val66Met polymorphism have been linked to elevated food intake and body weight. The mechanisms underlying this dysfunction are poorly defined. We demonstrate a chief role of α2δ-1, a calcium channel subunit and thrombospondin receptor, in triggering overeating in mice with central BDNF depletion. We show reduced α2δ-1 cell-surface expression in the BDNF mutant ventromedial hypothalamus (VMH), an energy balance-regulating center. This deficit contributes to the hyperphagia exhibited by BDNF mutant mice because selective inhibition of α2δ-1 by gabapentin infusion into wild-type VMH significantly increases feeding and body weight gain. Importantly, viral-mediated α2δ-1 rescue in BDNF mutant VMH significantly mitigates their hyperphagia, obesity, and liver steatosis and normalizes deficits in glucose homeostasis. Whole-cell recordings in BDNF mutant VMH neurons revealed normal calcium currents but reduced frequency of EPSCs. These results suggest calcium channel-independent effects of α2δ-1 on feeding and implicate α2δ-1-thrombospondin interactions known to facilitate excitatory synapse assembly. Our findings identify a central mechanism mediating the inhibitory effects of BDNF on feeding. They also demonstrate a novel and critical role for α2δ-1 in appetite control and suggest a mechanism underlying weight gain in humans treated with gabapentinoid drugs.
脑源性神经营养因子 (BDNF) 及其受体 TrkB 是控制食欲和体重的神经回路的关键组成部分。在小鼠中,BDNF 信号转导减弱会导致严重的过度摄食和肥胖。在人类中,BDNF 单倍不足和功能性 Bdnf Val66Met 多态性与食物摄入增加和体重增加有关。这种功能障碍的机制尚未明确定义。我们证明了 α2δ-1(钙通道亚基和血小板反应蛋白受体)在触发 BDNF 耗尽的小鼠过度进食中的主要作用。我们发现,在调节能量平衡的中心腹内侧下丘脑 (VMH) 的 BDNF 突变体中,α2δ-1 细胞表面表达减少。这种缺陷导致 BDNF 突变小鼠出现过度摄食,因为将加巴喷丁输注到野生型 VMH 中选择性抑制 α2δ-1 会显著增加摄食和体重增加。重要的是,通过病毒介导的 VMH 中 BDNF 突变体的 α2δ-1 挽救,显著减轻了它们的过度摄食、肥胖、肝脂肪变性,并使葡萄糖稳态的缺陷正常化。BDNF 突变 VMH 神经元的全细胞膜片钳记录显示正常的钙电流,但 EPSC 频率降低。这些结果表明 α2δ-1 对摄食有钙通道非依赖性影响,并暗示 α2δ-1-血小板反应蛋白相互作用已知可促进兴奋性突触组装。我们的发现确定了介导 BDNF 对摄食的抑制作用的中枢机制。它们还表明 α2δ-1 在食欲控制中的新的和关键作用,并提出了在接受加巴喷丁类药物治疗的人类中体重增加的潜在机制。